Anti-Interleukin 23 Biologic Are Mostly Effective and Safe in Psoriatic Patients Who Failed Anti-Interleukin 17. A Real-Life, Retrospective 52-Week Experience

• J. Arroyo-Andrés,
• D. Falkenhain-López,
• M. Agud-Dios,
• R. Rivera-Díaz

Affiliations

J. Arroyo-Andrés

Corresponding author.; Department of Dermatology, Hospital Universitario 12 de Octubre, Madrid, Spain

D. Falkenhain-López

Department of Dermatology, Hospital Universitario 12 de Octubre, Madrid, Spain

M. Agud-Dios

Department of Dermatology, Hospital Universitario 12 de Octubre, Madrid, Spain

R. Rivera-Díaz

Department of Dermatology, Hospital Universitario 12 de Octubre, Madrid, Spain